IMP dehydrogenase: structural schizophrenia and an unusual base

被引:48
作者
Hedstrom, Lizbeth
Gan, Lu
机构
[1] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA
[2] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1016/j.cbpa.2006.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Textbooks describe enzymes as relatively rigid templates for the transition state of a chemical reaction, and indeed an enzyme such as chymotrypsin, which catalyzes a relatively simple hydrolysis reaction, is reasonably well described by this model. Inosine monophosphate dehydrogenase (IMPDH) undergoes a remarkable array of conformational transitions in the course of a complicated catalytic cycle, offering a dramatic counterexample to this view. IMPDH displays several other unusual mechanistic features, including an Arg residue that may act as a general base catalyst and a dynamic monovalent cation site. Further, IMPDH appears to be involved in 'moon-lighting' functions that may require additional conformational states. How the balance between conformational states is maintained and how the various conformational states interconvert is only beginning to be understood.
引用
收藏
页码:520 / 525
页数:6
相关论文
共 39 条
[1]   On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa [J].
Aherne, A ;
Kennan, A ;
Kenna, PF ;
McNally, N ;
Lloyd, DG ;
Alberts, IL ;
Kiang, AS ;
Humphries, MM ;
Ayuso, C ;
Engel, PC ;
Gu, JJ ;
Mitchell, BS ;
Farrar, GJ ;
Humphries, P .
HUMAN MOLECULAR GENETICS, 2004, 13 (06) :641-650
[2]   Mycophenolate mofetil and its mechanisms of action [J].
Allison, AC ;
Eugui, EM .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :85-118
[3]   Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and Leber congenital amaurosis [J].
Bowne, SJ ;
Sullivan, LS ;
Mortimer, SE ;
Hedstrom, L ;
Zhu, JY ;
Spellicy, CJ ;
Gire, AI ;
Hughbanks-Wheaton, D ;
Birch, DG ;
Lewis, RA ;
Heckenlively, JR ;
Daiger, SP .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (01) :34-42
[4]   Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa [J].
Bowne, SJ ;
Sullivan, LS ;
Blanton, SH ;
Cepko, CL ;
Blackshaw, S ;
Birch, DG ;
Hughbanks-Wheaton, D ;
Heckenlively, JR ;
Daiger, SP .
HUMAN MOLECULAR GENETICS, 2002, 11 (05) :559-568
[5]   Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target [J].
Chong, CR ;
Qian, DZ ;
Pan, F ;
Wei, YF ;
Pili, R ;
Sullivan, DJ ;
Liu, JO .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) :2677-2680
[6]   Participation of yeast inosine 5′-monophosphate dehydrogenase in an in vitro complex with a fragment of the C-rich telomeric strand [J].
Cornuel, JF ;
Moraillon, A ;
Guéron, M .
BIOCHIMIE, 2002, 84 (04) :279-289
[7]   Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]-amino]-5-oxazolyl]phenyl]-N-methyl-4-morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity [J].
Dhar, TGM ;
Shen, ZQ ;
Guo, JQ ;
Liu, CJ ;
Watterson, SH ;
Gu, HH ;
Pitts, WJ ;
Fleener, CA ;
Rouleau, KA ;
Sherbina, NZ ;
McIntyre, KW ;
Witmer, MR ;
Tredup, JA ;
Chen, BC ;
Zhao, RL ;
Bednarz, MS ;
Cheney, DL ;
MacMaster, JF ;
Miller, LM ;
Berry, KK ;
Harper, TW ;
Barrish, JC ;
Hollenbaugh, DL ;
Iwanowicz, EJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (11) :2127-2130
[8]   Kinetic mechanism of Tritrichomonas foetus inosine 5′-monophosphate dehydrogenase [J].
Digits, JA ;
Hedstrom, L .
BIOCHEMISTRY, 1999, 38 (08) :2295-2306
[9]  
Franchetti P, 1999, CURR MED CHEM, V6, P599
[10]   The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase [J].
Gan, L ;
Seyedsayamdost, MR ;
Shuto, S ;
Matsuda, A ;
Petsko, GA ;
Hedstrom, L .
BIOCHEMISTRY, 2003, 42 (04) :857-863